MyJournals Home  

RSS FeedsPatient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery (British Journal of Cancer)

 
 

2 january 2020 02:00:04

 
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery (British Journal of Cancer)
 




 
399 viewsCategory: Oncology
 
The roles of RNA in DNA double-strand break repair (British Journal of Cancer)
Diagnostic value of plasma HSP90? levels for detection of hepatocellular carcinoma (BMC Cancer)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten